MetLife to Report Q2 Earnings: What Do Key Estimates Say?

04.08.25 15:44 Uhr

Werte in diesem Artikel
Aktien

69,44 EUR 0,87 EUR 1,27%

62,00 EUR 0,00 EUR 0,00%

Indizes

PKT PKT

17.792,1 PKT -115,1 PKT -0,64%

3.312,5 PKT 14,0 PKT 0,42%

6.643,7 PKT 39,0 PKT 0,59%

Leading global insurer MetLife, Inc. MET is set to report second-quarter 2025 results on Aug. 6, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $2.19 per share on revenues of $18.4 billion.The second-quarter earnings estimate has improved over the past 30 days. However, the bottom-line projection indicates a year-over-year decline of 4%. The Zacks Consensus Estimate for quarterly revenues suggests a year-over-year decline of 1.5%.Image Source: Zacks Investment ResearchFor the current year, the Zacks Consensus Estimate for MetLife’s revenues is pegged at $74.8 billion, implying a rise of 2.4% year over year. Also, the consensus mark for current-year EPS is pegged at $8.96, calling for a jump of around 10.5% on a year-over-year basis.MET beat the consensus estimate for earnings in one of the last four quarters and missed thrice, with the average surprise being negative 1.9%.MetLife, Inc. Price and EPS Surprise MetLife, Inc. price-eps-surprise | MetLife, Inc. QuoteQ2 Earnings Whispers for METOur proven model does not conclusively predict an earnings beat for MetLife this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.MET has an Earnings ESP of +0.67% and carries a Zacks Rank #4 (Sell) at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.What’s Shaping MET’s Q2 Results?Rising adjusted group benefits revenues are expected to buoy MetLife’s second-quarter results. Improving operations in the international markets, especially in Asia and Latin America, is a major positive.The Zacks Consensus Estimate for total adjusted group benefits for the to-be-reported quarter suggests an increase of 2.9% from the prior-year quarter. Improving profits from Asia and Latin American operations are expected to have positioned the company for significant growth from the year-ago period. Favorable underwriting and improved variable investment income are likely to have aided the Asia segment, while the Latin America business is expected to have gained from higher volumes.Adjusted earnings from the Latin America business are likely to have witnessed 0.4% year-over-year growth in the second quarter.The factors mentioned above are expected to have contributed to MetLife's year-over-year growth. However, rising costs and expenses are likely to have partially offset the profit growth levels in the to-be-reported quarter. Also, the consensus mark for net investment income is pegged at $5.1 billion, implying a decline of 1.4% year over year.Stocks That Warrant a LookHere are some companies worth considering from the broader Finance space, as our model shows that these have the right combination of elements to beat on earnings this time:Hippo Holdings Inc. HIPO presently has an Earnings ESP of +2.04% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Hippo Holdings’ bottom line for the to-be-reported quarter is pegged at a loss of $0.65 per share, indicating 60.4% year-over-year growth. It has remained stable over the past week. The consensus estimate for Hippo Holdings’ revenues is pegged at $115.5 million.American International Group Inc AIG currently has an Earnings ESP of +0.18% and carries a Zacks Rank #3.The Zacks Consensus Estimate for American International Group’s bottom line for the to-be-reported quarter is pegged at $1.58 per share, indicating 36.2% year-over-year growth. It has remained stable over the past week. The consensus estimate for American International Group’s revenues is pegged at $6.8 billion.Assurant, Inc. AIZ currently has an Earnings ESP of +2.21% and a Zacks Rank of 3.The Zacks Consensus Estimate for Assurant’s earnings for the to-be-reported quarter is pegged at $4.43 per share. The consensus estimate for revenues is pegged at $3.11 billion. Assurant beat earnings estimates in each of the past four quarters, with the average surprise being 16%.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American International Group, Inc. (AIG): Free Stock Analysis Report MetLife, Inc. (MET): Free Stock Analysis Report Assurant, Inc. (AIZ): Free Stock Analysis Report Hippo Holdings Inc. (HIPO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen